REVIEW
Liver transplantation for hepatitis C virus related liver disease
1 Department of Gastroenterology, Leicester Royal Infirmary, Leicester, UK
2 Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital, Cambridge, UK
Correspondence to:
Correspondence to:
Dr I Gee
Department of Gastroenterology, Level 2 Windsor Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK; igee{at}doctors.org.uk
Liver transplantation is a useful treatment for end stage liver disease of all aetiologies but recurrent disease presents an ongoing challenge, particularly for hepatitis C virus (HCV) where recurrence is almost universal. Immunosuppression is needed for all patients after transplantation and should be tailored to the individual patient, with particular problems being noted for those with HCV. The longer term effects of immunosuppression, particularly renal failure and the adverse effects of certain treatments on the liver graft, have become more important as survival improves and results are studied for longer periods after transplantation.
Abbreviations: HCV, hepatitis C virus; MMF, mycophenolate mofetil; NF-AT, nuclear factor of activated T cells
Keywords: liver transplantation; immunosuppression; hepatitis C virus
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
